On February 12th, Hangzhou Tigermed Consulting (Stock code: 03347) spent approximately 18.52 million yuan to repurchase 350,400 shares of A shares.
Tiger Pharmaceuticals (03347) announced a plan to spend approximately 18.52 million yuan to repurchase 35...
Hangzhou Tigermed Consulting (03347) announced that on February 12, 2025, it will spend approximately 18.52 million yuan to repurchase 350,400 A-shares.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
